期刊文献+

简易植入式硬膜外腔输注系统治疗区段性顽固性癌痛的临床研究 被引量:3

下载PDF
导出
摘要 据统计,75%~90%的晚期癌症患者伴有剧烈的疼痛症状,癌痛已成为倍受关注的医学、心理及社会问题.癌痛病因复杂,涉及到肿瘤压迫、转移、神经侵犯、炎症等综合因素,即便应用癌症疼痛三阶梯治疗方案,仍有10%~30%的患者存在难以控制的顽固性癌痛[1,2],且伴随镇痛药物引起的严重副作用.对此WHO专家推荐应用介入镇痛方法进行治疗,即第四阶梯镇痛方案,其中全植入式鞘内(蛛网膜下腔)吗啡镇痛泵创伤较大且费用昂贵,简易植入式鞘内镇痛的并发症较多,而硬膜外镇痛通过将局部麻醉药物和镇痛药物等注射到硬膜外腔,对区段脊神经进行阻滞,可以达到特定区域镇痛的效果[2~5].
出处 《中国疼痛医学杂志》 CAS CSCD 2015年第8期626-629,共4页 Chinese Journal of Pain Medicine
基金 北京市科学技术委员会首都临床特色应用研究专项资助课题(Z131107002213081) 北京希望马拉松专项基金资助
  • 相关文献

参考文献9

  • 1司马蕾,樊碧发,闫龙涛,水源,刘波涛,苗羽,杨阳,毛鹏,朱谦,杨克勤.神经病理性癌痛的临床特点与现状控制的调查研究[J].中国疼痛医学杂志,2014,20(7):476-480. 被引量:14
  • 2丁超,孙莉,吴晓明,张国华,于雷,孙海涛,王海,承耀中,董彦鹏.经椎管内硬膜外腔介入治疗胰腺癌致顽固性癌痛的临床研究[J].中国医刊,2015,50(3):49-53. 被引量:4
  • 3王昆(综述),王昆(审校).鞘内输注系统治疗顽固性癌痛[J].中国肿瘤临床,2013,40(18):1141-1144. 被引量:12
  • 4Mitchell P. Engle, Baominh P. Vinh, Nusrat Harun, et al. Infectious Complications Related to Intrathecal Drug Delivery System and Spinal Cord Stimulator System Implantations at a Comprehensive Cancer Pain Center. Pain Physician ,2013, 16:251 - 257.
  • 5Catherine E. Smyth, Virginia Jarvis, Patricia Poulin. Brief review: Neuraxial analgesia in refractory malignant pain. Can J Anesth, 2014,(61):141 - 153.
  • 6Smith TJ, Staats PS, Pool GE, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol, 2002, 20:4040 - 4049.
  • 7Smith TJ, Coyne PJ, Pool GE, et al. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol, 2005, 16:825- 833.
  • 8Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.Pain, 1995, 61:277 - 284.
  • 9Chochinov HM, Tataryn D, Clinch JJ, et al. Will to live in the terminally ill. Lancet, 1999, 354:816 - 819.

二级参考文献54

  • 1van den Beuken-van Everdingen MH, deRijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: A systematic review of the past 40 years[J]. Ann Oncol, 2007, 18(9):1437-1449.
  • 2Hawley P, Beddard-Huber E,Grose C, et al. Intrathecal infusions for intractable cancer pain: A qualitative study of the impact on a case series of patients and caregivers[J]. Pain Res Manag, 2009, 14 (5) :371-379.
  • 3Smith HS, Deer TR, Staats PS, et al. Intrathecal Drug Delivery[J]. Pain Physician, 2008, 11 (2S) :89-104.
  • 4Upadhyay SP, Mallick PN. Intrathecal drug delivery system (ID- DS) for cancer pain management: a review and updates[J], Am J Hosp Palliat Care, 2012, 29(5):388-398.
  • 5Knight KH, Brand FM, Mchaourab AS, et al. Implantable Intrathe- cal Pumps for Chronic Pain: Highlights and Updates[J]. Croat Med J, 2007, 48(1):22-34.
  • 6Lawson EF, Wallace MS. Advances in intrathecal drug delivery[J]. Curr Ophl Anaesthesiol, 2012, 25 (5):572-576.
  • 7Thimineur MA, Kravitz E, Vodapally MS.Intrathecal opioid treat- ment for chronicnonmalignant pain: A 3-year prospective study[J]. Pain, 2004, 109(3):242-249.
  • 8Pleticha J,Mans TP , Jeng-Singh C, et al. Pig lumbar spine anato- my and imaging-gxfided lateral lumbar puncture: A new large ani- mal model for intrathecal drug delivery[J]. J Neurosci Methods, 2013, 216(1):10-15.
  • 9Knight KH, Brand FM, Mchaourab AS, Veneziano G. hnplantable intrathecal pumps for chronic pain: Highlights and updates[]]. Cro- at MedJ, 2007,4 8(1):22-34.
  • 10Follet KA, Boortz-Marx RL, DrakeJM, et al. Prevention and man- agement of intrathecai drug delivery and spinal cord stimulation system infections[J]. Anesthesiology, 2004, 100(6):1582-1594.

共引文献27

同被引文献21

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部